PARTNERS Trial Begins Patient Enrolment for Bundibugyo Ebola Treatments
The WHO-sponsored study in the Democratic Republic of the Congo will evaluate monoclonal antibody MBP134 and remdesivir as potential therapies for Bundibugyo virus disease.
The WHO-sponsored study in the Democratic Republic of the Congo will evaluate monoclonal antibody MBP134 and remdesivir as potential therapies for Bundibugyo virus disease.
The newly listed test detects Bundibugyo virus by identifying its genetic material in blood samples, enabling rapid and accurate confirmation of infection.
Patients and healthcare providers are advised not to use any DARZALEX products bearing batch numbers MYS7381 or STV1K01.
SK bioscience, PATH, Slalom, and SK AX are developing an AI-powered platform under the Gates Foundation-funded ROTOR project to advance rotavirus vaccine development and improve vaccine access in LMICs.
The US FDA inspected Lupin’s manufacturing facility in Somerset, New Jersey, from April 13 to April 17, 2026.
Rising GERD prevalence, increasing adoption of reflux diagnostic tools, growing demand for minimally invasive anti-reflux procedures, and expanding hospital endoscopy infrastructure are driving growth in the global GERD device market.
The partnership between Suzhou Ribo Life Science and Madrigal Pharmaceuticals focuses on developing RNA-based therapeutics for metabolic dysfunction-associated steatohepatitis (MASH).
Under the agreement, Insilico will lead the AI-driven discovery process to identify molecules that meet predefined scientific and early development criteria, while Takeda will leverage its global development capabilities to advance selected candidates through clinical validation.
The transfer was executed on a slump sale basis in accordance with the Business Transfer Agreement (BTA) signed between Aurobindo Pharma and Auropharm.
Roche has announced that the US Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental Biologics License Application (sBLA) for Enspryng (satralizumab) as a potential treatment for thyroid eye disease (TED). TED, also known as Graves’ ophthalmopathy, is a rare autoimmune inflammatory disease that affects the area around the eyes […]